NCT03792165

Brief Summary

The investigators aim to explore the effects of action observation therapy on pain and brain hemodynamics in patients with knee osteoarthritis. This study will create a new perspective to understand the physiology of pain, by applying painful stimulation during the neuroimaging system which has attracted much interest in the literature in recent years, and will shed light on the studies that can be done in this regard. Participants' pain level will be assessed using Visual Analog Scale and pressure algometer. Also joint range of motion in the initial assessments will be measured by electro-goniometer, muscle strength assessment by JTech hand dynamometer at appropriate evaluation positions. Fear of movement of individuals will be assessed via Tampa Kinesiophobia Scale and functional levels will be assessed via Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Timed Up and Go Test. Functional near infrared spectroscopy (fNIRS) will be used for evaluation of brain hemodynamics. The first group, will receive exercises with action observation therapy; and the second group will receive only exercises. The exercise programme will be administered under physiotherapist supervision for three days a week for six weeks. The evaluations will be repeated at the beginning of the study and at the end of the sixth week. Data obtained from the study will be analyzed using appropriate statistical methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 3, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

February 11, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2019

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2019

Completed
Last Updated

July 18, 2022

Status Verified

July 1, 2022

Enrollment Period

5 months

First QC Date

December 28, 2018

Last Update Submit

July 15, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in brain activation in dorsolateral prefrontal cortex as assessed by fNIRS monitoring (measure of hemodynamic response function)

    In order to assess the brain hemodynamics during the painful and non painful stimulations of patients functional near infrared spectroscopy (NIRX Medical Technologies NIRScout) will be used. This neuroimaging method will be applied with 16 detector and 16 source which implanted via a cap. Firstly, the patients' pain pressure threshold level at knee region will be determined, then this value will be considered as painful stimulation. For non-painful stimulation 5 N will be applied to the patient. Hemodynamic responses will be evaluated according to the cortical areas (prefrontal cortex, premotor and supplementary motor cortex, primer motor cortex, primer somatosensory cortex)

    6 weeks

  • Pain Level

    Self reported pain intensity during the rest and the activity measured by Visual Analog Scale which presented as a 10 centimeter horizontal line and 0 means no pain, 10 means unbearable pain.

    6 weeks

  • Pressure pain threshold

    Algometer (dolorimeter) will be used to assess the pressure pain threshold, whereby the medial middle point of the knee and 2 cm lateral to the medial malleol.

    6 weeks

Secondary Outcomes (4)

  • Kinesiophobia

    6 weeks

  • Western Ontario and Mcmaster Universities Osteoarthritis Index

    6 weeks

  • Muscle strength

    6 weeks

  • Range of motion

    6 weeks

Study Arms (2)

Action observation therapy and exercise

EXPERIMENTAL

Video of normal human movement and Strengthening and stretching exercises for hip and knee muscles

Other: Action observation therapyOther: Exercise

Exercise

ACTIVE COMPARATOR

Strengthening and stretching exercises for hip and knee muscles, balance and proprioceptive exercises

Other: Exercise

Interventions

The normal human movement will be recorded and than the patients will be watched them.

Action observation therapy and exercise

Strengthening and stretching exercise programme focuses on hip and knee muscles

Action observation therapy and exerciseExercise

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MMSE\>21
  • Chronic knee pain (VAS score\>5)
  • Right dominant
  • Unilateral knee pain

You may not qualify if:

  • Pain characteristics such as the presence of a rheumatologic disease other than knee osteoarthritis, lumbar radiculopathy, systemic inflammatory disease, diabetic neuropathy, problems similar to knee osteoarthritis,
  • Hearing or vision problems,
  • Injection therapy involving the knee region within the last 6 months,
  • Surgical operation involving the knee region
  • Psychiatric problems and anti-depressant usage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Özgül Öztürk

Istanbul, 34752, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis, KneeMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

December 28, 2018

First Posted

January 3, 2019

Study Start

February 11, 2019

Primary Completion

July 8, 2019

Study Completion

July 10, 2019

Last Updated

July 18, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations